Loading

Review Article Open Access
Volume 2 | Issue 5 | DOI: https://doi.org/10.33696/immunology.2.045

Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases

  • 1Aab Cardiovascular Research Institute, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14642, USA
  • 2Department of Pharmacology and Physiology, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14642, USA
+ Affiliations - Affiliations

Corresponding Author

Chen Yan, Chen_Yan@urmc.rochester.edu

Received Date: June 03, 2020

Accepted Date: July 08, 2020

Abstract

Vinpocetine is a derivative of vincamine. It has been used to prevent and treat cerebrovascular disorders such as stoke and dementia, and remains widely available in dietary supplements that often marketed as nootropics. Due to its excellent safety profile at therapeutic dose regimen, vinpocetine has raised research interest in its new applications in various experimental disease models. Here we review recent studies that uncovered novel functions of vinpocetine in cardiovascular diseases, including atherosclerosis, obesity, neointimal hyperplasia, vasoconstriction, pathological cardiac remodeling and ischemia stroke. Molecular mechanisms underlined the protective effects of vinpocetine are also discussed. These novel findings may suggest a broadened usage of vinpocetine against relevant cardiovascular diseases in human.

Keywords

Vinpocetine, Vascular disease, Cardiac remodeling, Stroke, Inflammation

Author Information X